Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Clinical trial NCT03885037 · COMPLETED

Trial details

NCT number: NCT03885037
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2019-03-20
Primary completion: 2024-11-29
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.